Company registration number 08132942 (England and Wales)
IBIDEM CAPITAL LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
IBIDEM CAPITAL LIMITED
COMPANY INFORMATION
Directors
Mr T J Jakob
Mr T C Holmes
Ms J R Olkkola
(Appointed 24 July 2024)
Mr W S Bell
(Appointed 24 July 2024)
Company number
08132942
Registered office
Jessop House
Jessop Avenue
Cheltenham
Gloustershire
United Kingdom
GL50 3SH
Auditor
Azets Audit Services
Epsilon House
The Square
Gloucester Business Park
Gloucester
United Kingdom
GL3 4AD
IBIDEM CAPITAL LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Group statement of comprehensive income
8
Group balance sheet
9
Company balance sheet
10
Group statement of changes in equity
11
Company statement of changes in equity
12
Group statement of cash flows
13
Notes to the financial statements
14 - 38
IBIDEM CAPITAL LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -

The directors present the strategic report for the year ended 31 December 2024.

Fair review of the business

The results for the year and the financial position at the year-end were considered satisfactory by the directors who expect continued revenue growth in the foreseeable future.

 

The group continues to invest in the business - attracting new customers, enhancing technology and transitioning to in-house capabilities, with less utilisation of third parties. These investments are paying off with continued revenue growth and gross profit enhancement supporting the group's plans to profitability.

 

The group measures its performance against several key performance indicators (KPIs):

 

KPIs

2024

£000

2023

£000

Revenue

29,161

25,358

Gross Profit

10,527

8,966

GP %

36.10%

35.36%

EBITDA profits/(losses)

1,453

(99)

 

Revenue for the year increased by 15% to £29.2m reflecting high customer retention, the roll out of new payrolls from customers acquired in prior years along with additional revenue streams. The group expects this growth to continue having had a very successful 2024, winning new customers and expanding its footprint with existing customers.

 

As expected, the group has been profitable throughout the year at the EBITDA level. The total loss before tax for the year was £5.3m (2023: £5.5m). These were planned losses with significant growth expenditure being expensed.

 

Description of principal risks and uncertainties

The group's business is subject to a number of risks and uncertainties. The directors consider the following to be the key risks and uncertainties:

 

Funding and liquidity risk

The business manages its cash and borrowing requirements in order to maximise interest income and minimise interest expense, whilst ensuring the business has sufficient liquid resources to meet the operating needs of the business.

 

Interest rate cash flow risk

The business is exposed to potential upward movements in EUR Libor rate. With inflation now under control within the European Union and Euribor rates beginning to decline, the business does not expect to see any material growth in interest expense over the coming year.

 

Competition

The business operates in a highly competitive environment. To date, the business has been very successful in growing and retaining its customer base. The directors expect continued competitive pressures given advancements in technology and efficiencies.

 

Credit risk

All customers who wish to trade on credit terms are subject to credit verification procedures. Trade debtors are monitored on an ongoing basis and provision is made for doubtful debts, where necessary.

 

Foreign currency risk

The business’s principal foreign currency exposures arise from trading with overseas entities and operating within a EUR debt facility agreement. The risk is minimised through partial hedging, with traded currencies (receipts and payments) limited as far as possible to GBP, USD and EUR.

IBIDEM CAPITAL LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
Description of principal risks and uncertainties (continued)

 

Data protection risk

The business is responsible to its customers for ensuring that customer data is adequately protected. The business has developed robust infrastructure and follows industry accepted policies and procedures as required under the certification of ISO 27001 and SOC 1. Our certification audits in 2024 highlighted no material deviations. The business has outsourced its data centre operations to third parties who operate at industry recognised standards. A material data breach would have an adverse financial impact.

 

Technology risk

The business has built its own robust, proprietary technology that has been in operation for a number of years with frequent upgrades and new functionality. Business continuity plans have been developed and tested to ensure that the business will continue to operate under various scenarios.

Development and performance

The directors consider the following factors to be key in analysing the development and performance of the business.

 

- Revenue growth;

- Gross profit improvement;

- EBITDA growth; and

- Value of new contracts won.

Research and development ("R&D")

Part of the business's activities are directed towards R&D. In its widest sense, R&D encompasses the use of scientific or technological knowledge in order to produce new or substantially improved materials, devices, products or services to install new processes and systems prior to the commencement of commercial production or application, or to improve substantially materials, devices, products or services already produced or installed.

 

The directors consider that the development of new software applications and other advancements being developed fall within this definition.

On behalf of the board

Mr T J Jakob
Director
2 May 2025
IBIDEM CAPITAL LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the company and group continued to be that of the provision of international payroll services.

Results and dividends

The results for the year are set out on page 8.

No ordinary dividends were paid. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr T J Jakob
Mr J K Hustis
(Resigned 9 July 2024)
Mr T C Holmes
Mr V Davidson
(Resigned 9 July 2024)
Ms J R Olkkola
(Appointed 24 July 2024)
Mr W S Bell
(Appointed 24 July 2024)
Employee involvement

The group's policy is to consult and discuss with employees matters likely to affect employees' interests.

 

Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the group's performance.

Post reporting date events

Information relating to post reporting date events is given in the notes to the financial statements.

Statement of directors' responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

IBIDEM CAPITAL LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

Disclosure in the Strategic Report

The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the group strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report.

On behalf of the board
Mr T J Jakob
Director
2 May 2025
IBIDEM CAPITAL LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF IBIDEM CAPITAL LIMITED
- 5 -
Opinion

We have audited the financial statements of Ibidem Capital Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

IBIDEM CAPITAL LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF IBIDEM CAPITAL LIMITED
- 6 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

IBIDEM CAPITAL LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF IBIDEM CAPITAL LIMITED
- 7 -

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above and on the Financial Reporting Council’s website, to detect material misstatements in respect of irregularities, including fraud.

 

We obtain and update our understanding of the group, its activities, its control environment, and likely future developments, including in relation to the legal and regulatory framework applicable and how the group is complying with that framework. Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. This includes consideration of the risk of acts by the group that were contrary to applicable laws and regulations, including fraud.

 

In response to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included:

 

 

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Robert Hull (Senior Statutory Auditor)
For and on behalf of Azets Audit Services
6 May 2025
Chartered Accountants
Statutory Auditor
Epsilon House
The Square
Gloucester Business Park
Gloucester
United Kingdom
GL3 4AD
IBIDEM CAPITAL LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
2024
2023
Notes
£
£
Turnover
3
29,161,134
25,357,955
Cost of sales
(18,633,654)
(16,391,680)
Gross profit
10,527,480
8,966,275
Administrative expenses
(10,306,550)
(9,516,457)
Operating profit/(loss)
4
220,930
(550,182)
Interest receivable and similar income
9
46,203
17,384
Interest payable and similar expenses
10
(5,541,636)
(4,031,366)
Exceptional items
10
(73,843)
(959,548)
Loss before taxation
(5,348,346)
(5,523,712)
Tax on loss
12
(72,500)
2,380,610
Loss for the financial year
26
(5,420,846)
(3,143,102)
Loss for the financial year is all attributable to the owner of the parent company.
Total comprehensive income for the year is all attributable to the owner of the parent company.
IBIDEM CAPITAL LIMITED
GROUP BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 9 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
13
2,544,366
2,311,893
Tangible assets
14
221,138
268,645
2,765,504
2,580,538
Current assets
Debtors falling due after more than one year
17
3,213,543
3,324,801
Debtors falling due within one year
17
9,988,767
8,639,100
Cash at bank and in hand
2,999,163
2,418,741
16,201,473
14,382,642
Creditors: amounts falling due within one year
19
(6,412,550)
(5,841,571)
Net current assets
9,788,923
8,541,071
Total assets less current liabilities
12,554,427
11,121,609
Creditors: amounts falling due after more than one year
20
(26,634,331)
(19,955,429)
Net liabilities
(14,079,904)
(8,833,820)
Capital and reserves
Called up share capital
23
1,485,327
1,485,327
Share premium account
24
25,350,609
25,350,609
Retranslation reserve
25
9,358
(165,404)
Profit and loss reserves
26
(40,925,198)
(35,504,352)
Total equity
(14,079,904)
(8,833,820)
The financial statements were approved by the board of directors and authorised for issue on 2 May 2025 and are signed on its behalf by:
02 May 2025
Mr T J Jakob
Director
IBIDEM CAPITAL LIMITED
COMPANY BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 10 -
2024
2023
Notes
£
£
£
£
Fixed assets
Investments
15
44,609,889
26,642,989
Current assets
Debtors
17
3,903,185
108,584
Cash at bank and in hand
1,198
1,192
3,904,383
109,776
Creditors: amounts falling due within one year
19
(145,746)
(219,048)
Net current assets/(liabilities)
3,758,637
(109,272)
Total assets less current liabilities
48,368,526
26,533,717
Creditors: amounts falling due after more than one year
20
(27,308,462)
-
Net assets
21,060,064
26,533,717
Capital and reserves
Called up share capital
23
1,485,327
1,485,327
Share premium account
24
25,350,609
25,350,609
Profit and loss reserves
26
(5,775,872)
(302,219)
Total equity
21,060,064
26,533,717

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s loss for the year was £5,473,653 (2023 - £25,901 profit).

The financial statements were approved by the board of directors and authorised for issue on 2 May 2025 and are signed on its behalf by:
02 May 2025
Mr T J Jakob
Director
Company registration number 08132942 (England and Wales)
IBIDEM CAPITAL LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 11 -
Share capital
Share premium account
Re- translation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 1 January 2023
1,359,754
21,156,455
(199,156)
(32,361,250)
(10,044,197)
Year ended 31 December 2023:
Loss and total comprehensive income
-
-
-
(3,143,102)
(3,143,102)
Issue of share capital
23
125,573
4,194,154
-
-
4,319,727
Currency translation differences
-
-
33,752
-
33,752
Balance at 31 December 2023
1,485,327
25,350,609
(165,404)
(35,504,352)
(8,833,820)
Year ended 31 December 2024:
Loss and total comprehensive income
-
-
-
(5,420,846)
(5,420,846)
Currency translation differences
-
-
174,762
-
174,762
Balance at 31 December 2024
1,485,327
25,350,609
9,358
(40,925,198)
(14,079,904)
IBIDEM CAPITAL LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 12 -
Share capital
Share premium account
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 January 2023
1,359,754
21,156,455
(328,120)
22,188,089
Year ended 31 December 2023:
Profit and total comprehensive income for the year
-
-
25,901
25,901
Issue of share capital
23
125,573
4,194,154
-
4,319,727
Balance at 31 December 2023
1,485,327
25,350,609
(302,219)
26,533,717
Year ended 31 December 2024:
Loss and total comprehensive income for the year
-
-
(5,473,653)
(5,473,653)
Balance at 31 December 2024
1,485,327
25,350,609
(5,775,872)
21,060,064
IBIDEM CAPITAL LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 13 -
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from/(absorbed by) operations
32
264,856
(6,016,221)
Interest paid
(1,297,739)
(1,225,794)
UK income taxes refunded
-
315,308
Foreign income taxes paid
(502,912)
(285,373)
Net cash outflow from operating activities
(1,535,795)
(7,212,080)
Investing activities
Purchase and development of intangible assets
(1,390,878)
(1,471,601)
Purchase of tangible fixed assets
(120,153)
(214,589)
Proceeds from disposal of tangible fixed assets
-
32,116
Interest received
23,136
9
Net cash used in investing activities
(1,487,895)
(1,686,181)
Financing activities
Proceeds from issue of shares
-
4,319,727
Proceeds from borrowings
3,414,103
4,575,073
Net cash generated from financing activities
3,414,103
8,894,800
Net increase/(decrease) in cash and cash equivalents
390,413
(3,461)
Cash and cash equivalents at beginning of year
2,418,741
2,343,352
Effect of foreign exchange rates
190,009
78,850
Cash and cash equivalents at end of year
2,999,163
2,418,741
IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 14 -
1
Accounting policies
Company information

Ibidem Capital Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is Festival House, Jessop Avenue, Cheltenham, Gloucestershire, United Kingdom, GL50 3SH.

 

The group consists of Ibidem Capital Limited and all of its subsidiaries.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

 

1.2
Business combinations

In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.

 

Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 15 -
1.3
Basis of consolidation

The consolidated group financial statements consist of the financial statements of the parent company Ibidem Capital Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.

 

All financial statements are made up to 31 December 2024. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

1.4
Going concern

The group made losses in both 2023 and 2024 and had net liabilities at 31 December 2024. These were planned losses with significant growth investment expensed each year. During 2022, the group successfully refinanced its existing external debt to a new lender with a €20,000,000 facility agreed which was subsequently extended to €23,000,000 and fully drawn down in the current year.

 

During the current year, the group then entered into an arrangement with this third-party lender whereby all amounts owed under the amended facility as described above were novated from the subsidiary, Integrated International Payroll Limited ("iiPay") to the parent company, Ibidem Capital Limited ("Ibidem"), in return for iiPay owing the same amount to Ibidem. Teakwood Capital, the group’s majority investor since February 2016, also provided further financing of $3,000,000 to the group before the current year end.

 

On 27 February 2025, TeakiiPay Holdings, LLC, the parent of the group entered into an Equity Purchase Agreement whereby its entire equity interest in the group has been sold to a third party, subject to FCA regulatory approval. The acquisition is on a debt-free and cash-free basis and on completion all third-party debt shall be repaid in full. Completion is expected in the second quarter of 2025.

 

Notwithstanding this, the directors have prepared forecasts for a period in excess of 12 months from the approval of the financial statements taking into consideration reasonable cash flow sensitivities. Looking towards the remainder of 2025 and beyond, the directors are confident that the group can meet its liabilities as they fall due using its available cash resources and with the ongoing operational and financial support of Teakwood Capital and the companies within the group. These companies have confirmed their ongoing operational and financial support for each other for a period of at least 12 months from approval of these financial statements.

At the time of approving the financial statements, the directors therefore have a reasonable expectation that the group has adequate resources to continue in operational existence for a period of at least 12 months from the date of approval of the financial statements and thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 16 -
1.5
Turnover

Turnover is measured at the fair value of consideration received or receivable and represents amounts for services provided to third parties in the normal course of business during the period, net of value added tax and any discounts, and results from the principal activity of the group.

 

Each element of turnover (described below) is recognised only when:

 

 

Income from payroll processing and any related support, maintenance and unit based licencing arrangements is recognised rateably over the initial term of the related customer contract.

 

Any income arising from pure consultancy work is recognised in profit or loss on a time and materials basis.

Services that have been provided at the end of a financial period, but which have not been invoiced at the time, are recognised as turnover in profit or loss and shown within prepayments and accrued income on the balance sheet.

 

Implementation and set-up fees in connection with the provision of payroll processing services are deferred until such initial work is considered complete and is then recognised rateably over the remaining term of the related customer contract.

 

Advance payments from customers or advance invoicing at the end of the financial period are included within accruals and deferred income on the balance sheet. Such amounts are recognised in profit or loss when the services are provided to the customer in accordance with the points set out above.

1.6
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.7
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of a business over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 17 -
1.8
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets comprise both licence and development costs for computer software, and development costs on internally generated intangibles related to creating new and improved interfaces, dashboards and security features to enhance the customer experience. Such assets are defined as having finite useful lives and the costs are amortised on a straight line basis over their estimated useful lives. Intangible assets are stated at cost less amortisation and are reviewed for impairment whenever there is an indication that the carrying value may be impaired.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer software
3 to 10 years straight line
Development costs
3 years straight line
1.9
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
5 years straight line
Fixtures and fittings
5 years straight line
Computers
3 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

1.10
Fixed asset investments

In the parent company financial statements, interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in or .

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.11
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

 

The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 18 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.12
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.13
Financial instruments

Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 19 -
Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 20 -
Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.14
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.15
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.16
Provisions

Provisions are recognised when the group has a legal or constructive present obligation as a result of a past event, it is probable that the group will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 21 -
1.17
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.18
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.19
Share-based payments

Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using an option pricing model considered appropriate by the directors. The fair value determined at the grant date is expensed over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.

1.20
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

1.21
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

1.22

Deferred costs

Costs in respect of implementation and set-up fees are deferred until such initial work is considered complete and are then recognised rateably over the remaining term of the related customer contract. Deferred costs are included within prepayments and accrued income on the balance sheet.

1.23

Related parties

The company has taken advantage of exemption under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' not to disclose related party transactions with wholly owned subsidiaries within the group.

1.24

Exceptional items

Exceptional items are those which are separately identified by virtue of their size or nature to allow a full understanding of the underlying performance of the group or company.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 22 -
2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Recoverability of amounts due from group undertakings

The company determines whether amounts receivable from group undertakings require impairment or whether a provision against the amounts is required. Determining whether the amounts receivable are impaired is based on the ability of the group entities to generate sufficient cash in the future to enable repayment of the debt. Where expected cash generated is lower than the amounts due to the company, an impairment loss may arise, or a provision may be required to reflect the risk that the full amount is not recovered. After reviewing the business environment and the company's expected future cash flows, management concluded that there was no impairment of amounts due from group undertakings at the current year end.

Impairment of investments in subsidiaries

The company conducts impairment reviews of investments in subsidiaries whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable or tests for impairment annually in accordance with the relevant accounting standards. Determining whether an asset is impaired requires an estimation of the recoverable amount which requires the company to estimate the value in use which is based on future cash flows and a suitable discount factor in order to calculate the present value. Where the actual cash flows are less than expected, an impairment loss may arise. After reviewing the business environment and the company's strategies and past performance of its cash generating units, management concluded that there was no impairment of investments in subsidiaries at the current year end.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
2
Judgements and key sources of estimation uncertainty
(Continued)
- 23 -
Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Deferred costs

Income generated from implementation and set-up fees for work performed on new customer contracts is deferred and released rateably over the remaining term of the customer contract when work is considered complete. The related costs are also deferred and released rateably over the same period. The value of costs deferred are a combination of an estimated allocation of internal staff costs and associated overhead costs, and actual third-party costs incurred.

Recognition of deferred tax asset

Deferred tax assets are required to be recognised to the extent that it is probable (i.e. more likely than not) that sufficient future taxable profits will be available against which the deductible temporary difference or unused tax losses or credits can be recovered or utilised.

 

Deferred tax assets are reviewed at each reporting date. In considering their recoverability, the company assesses the likelihood of these being recovered within a reasonably foreseeable timeframe, being typically a minimum of two years, taking into account the future expected profit profile and business model of each relevant company or country, and any potential legislative restrictions on use. Short-term timing differences are generally recognised ahead of losses and other tax attributes as being likely to reverse more quickly.

 

The consideration on whether to recognise a deferred tax asset therefore requires management to make judgements on whether future financial performance will allow previously accumulated taxable losses to be utilised against forecast taxable profits.

 

In making this judgement, management have considered the future financial performance of the business as part of its normal forecasting cycle and have therefore recognised a deferred tax asset of £2,500,000 accordingly, using a rate of 25%.

 

The estimate takes account of the inherent uncertainties constraining the expected level of profit as appropriate. Changes in these estimates will affect future profits and therefore the recoverability of the deferred tax assets.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 24 -
3
Turnover and other revenue
2024
2023
£
£
Turnover analysed by class of business
Rendering of services
29,161,134
25,357,955
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
4,316,087
5,034,984
Europe
15,318,264
13,759,643
North America
4,234,987
2,615,807
Rest of the World
5,291,796
3,947,521
29,161,134
25,357,955
2024
2023
£
£
Other revenue
Interest income
46,203
17,384
4
Operating profit/(loss)
2024
2023
£
£
Operating profit/(loss) for the year is stated after charging/(crediting):
Exchange differences apart from those arising on financial instruments measured at fair value through profit or loss
(864,699)
(365,217)
Depreciation of owned tangible fixed assets
153,522
140,012
Amortisation of intangible assets
1,157,296
1,270,400
Impairment of intangible assets
-
0
719,943
Operating lease charges
302,074
290,884
5
Auditor's remuneration
2024
2023
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
12,500
12,500
Audit of the financial statements of the company's subsidiaries
95,500
79,500
108,000
92,000
IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 25 -
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2024
2023
2024
2023
Number
Number
Number
Number
Directors
4
4
-
-
Operations
252
222
-
-
Support
94
73
-
-
Total
350
299
-
0
-
0

Their aggregate remuneration comprised:

Group
Company
2024
2023
2024
2023
£
£
£
£
Wages and salaries
14,171,673
12,263,374
-
0
-
0
Social security costs
2,048,171
1,613,311
-
-
Pension costs
192,110
173,014
-
0
-
0
16,411,954
14,049,699
-
0
-
0
7
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
192,110
173,014

A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 26 -
8
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
684,866
730,249
Company pension contributions to defined contribution schemes
10,054
18,859
694,920
749,108
Remuneration disclosed above includes the following amounts paid to the highest paid director:
2024
2023
£
£
Remuneration for qualifying services
393,780
410,686

 

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 1 (2023 - 1).

 

The number of directors who are entitled to receive shares under long-term incentive schemes during the year was 2 (2023 - 2).

 

There are no key management personnel other than directors and therefore the group has taken advantage of the exemption available under FRS 102 section 33.7A not to disclose this amount.

 

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 27 -
9
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest on bank deposits
15
9
Other interest income
46,188
17,375
Total income
46,203
17,384
10
Interest payable and similar expenses
2024
2023
£
£
Interest on financial liabilities measured at amortised cost:
Other interest on financial liabilities
5,541,636
4,031,366
Disclosed on the profit and loss account as follows:
Interest payable and similar expenses
5,541,636
4,031,366
11
Exceptional items

Group

 

Current year

Exceptional items of £73,843 in the current year include £12,840 employee severance costs, £42,948 professional fees and other exceptional costs of £18,055 incurred outside of the normal course of business.

 

Prior year

Exceptional items of £959,548 in the current year include an impairment to an intangible fixed asset of £719,943, £106,551 employee severance costs, £46,143 professional fees incurred outside of the normal course of business and £86,911 accrued in relation to unpaid taxes and interest on an employee share scheme.

 

Company

Exceptional items in the current year of £5,358,579 for the company relate to a provision for impairment of the investment held in relation to a subsidiary undertaking. This reverses on consolidation and has no impact on the results of the group.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 28 -
12
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
(238,688)
(249,538)
Adjustments in respect of prior periods
-
0
(49,259)
Total UK current tax
(238,688)
(298,797)
Foreign current tax on profits for the current period
311,188
418,187
Total current tax
72,500
119,390
Deferred tax
Tax losses carried forward
-
0
(2,500,000)
Total tax charge/(credit)
72,500
(2,380,610)

The actual charge/(credit) for the year can be reconciled to the expected credit for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Loss before taxation
(5,348,346)
(5,523,712)
Expected tax credit based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.50%)
(1,337,087)
(1,298,072)
Tax effect of expenses that are not deductible in determining taxable profit
560,450
687,295
Tax effect of utilisation of tax losses not previously recognised
596,720
518,334
Change in unrecognised deferred tax assets
714,123
(1,891,135)
Effect of change in corporation tax rate
-
(36,107)
Research and development tax credit
(238,688)
(249,538)
Effect of overseas tax rates
52,885
197,937
Under/(over) provided in prior years
-
0
(49,259)
Additional R & D tax relief
(275,903)
(255,220)
Other
-
0
(4,845)
Taxation charge/(credit)
72,500
(2,380,610)

Losses have been incurred for UK tax purposes and are available for use against future taxable profits. A deferred tax asset has not been recognised in full as the group does not anticipate all of these losses to be utilised in the immediate future. The approximate value of the total unrecognised deferred tax asset measured at a standard rate of 25% (2023: 25%) is £4,720,000 (2023: £4,005,000).

 

Factors that may affect future tax charges

The main rate of UK Corporation Tax increased from 19% to 25% with effect from 1 April 2023.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 29 -
13
Intangible fixed assets
Group
Goodwill
Computer software
Development costs
Total
£
£
£
£
Cost
At 1 January 2024
65,897
2,374,097
6,163,035
8,603,029
Additions
-
0
34,822
1,356,056
1,390,878
Exchange adjustments
-
0
28,675
18,436
47,111
At 31 December 2024
65,897
2,437,594
7,537,527
10,041,018
Amortisation and impairment
At 1 January 2024
65,897
2,186,638
4,038,601
6,291,136
Amortisation charged for the year
-
0
58,921
1,098,375
1,157,296
Exchange adjustments
-
0
30,121
18,099
48,220
At 31 December 2024
65,897
2,275,680
5,155,075
7,496,652
Carrying amount
At 31 December 2024
-
0
161,914
2,382,452
2,544,366
At 31 December 2023
-
0
187,459
2,124,434
2,311,893
The company had no intangible fixed assets at 31 December 2024 or 31 December 2023.

Included within Development costs is an individual asset with a carrying amount of £489,306 and a remaining useful life of 36 months, and another individual asset with a carrying amount of £222,754 and a remaining useful life of 24 months.

Intangible fixed assets held are pledged as security for the borrowings of the group under fixed and floating charges.

 

The amortisation charge is included in Administrative expenses in the Group Statement of Comprehensive Income.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 30 -
14
Tangible fixed assets
Group
Leasehold improvements
Fixtures and fittings
Computers
Total
£
£
£
£
Cost
At 1 January 2024
37,445
68,223
949,067
1,054,735
Additions
-
0
-
0
123,993
123,993
Disposals
-
0
-
0
(41,698)
(41,698)
Exchange adjustments
(1,989)
(2,569)
(5,046)
(9,604)
At 31 December 2024
35,456
65,654
1,026,316
1,127,426
Depreciation and impairment
At 1 January 2024
32,003
58,158
695,929
786,090
Depreciation charged in the year
4,553
6,645
142,324
153,522
Eliminated in respect of disposals
-
0
-
0
(9,582)
(9,582)
Exchange adjustments
(1,825)
(2,163)
(19,754)
(23,742)
At 31 December 2024
34,731
62,640
808,917
906,288
Carrying amount
At 31 December 2024
725
3,014
217,399
221,138
At 31 December 2023
5,442
10,065
253,138
268,645
The company had no tangible fixed assets at 31 December 2024 or 31 December 2023.

Tangible fixed assets held are pledged as security for the borrowings of the group under fixed and floating charges.

 

The depreciation charge is included in Administrative expenses in the Group Statement of Comprehensive Income.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 31 -
15
Fixed asset investments
Group
Company
2024
2023
2024
2021 as restated
Notes
£
£
£
£
Investments in subsidiaries
16
-
0
-
0
44,609,889
26,642,989

Fixed asset investments held are pledged as security for the borrowings of the group under fixed and floating charges.

Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 January 2024
26,642,989
Additions
23,325,479
At 31 December 2024
49,968,468
Impairment
At 1 January 2024
-
Impairment losses
5,358,579
At 31 December 2024
5,358,579
Carrying amount
At 31 December 2024
44,609,889
At 31 December 2023
26,642,989
IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 32 -
16
Subsidiaries

Details of the company's subsidiaries at 31 December 2024 are as follows:

Name of undertaking
Address
Nature of business
Class of
% Held
shares held
Direct
Indirect
Integrated International Payroll (Holdings) Limited
See 1 below
Interim holding company
Ordinary shares
100.00
-
Integrated International Payroll Limited
See 2 below
Provision of  international payroll  services
Ordinary shares
0
100.00
Integrated International Payroll (Hong Kong) Limited
See 3 below
Dormant
Ordinary shares
0
100.00
Integrated International Payroll SARL
See 4 below
Provision of  international payroll  services
Ordinary shares
0
100.00
Integrated International Payroll KFT
See 5 below
Provision of  international payroll  services
Ordinary shares
0
100.00
Integrated International Payroll SP ZOO
See 6 below
Provision of  international payroll  services
Ordinary shares
0
100.00
Integrated International Payroll (PTE.) LTD.
See 7 below
Provision of  international payroll  services
Ordinary shares
0
100.00
Integrated International Payroll LLC
See 8 below
Provision of  international payroll  services
Ordinary shares
0
100.00
IIPROLL MEXICO, S.A DE C.V
See 9 below
Provision of  international payroll  services
Ordinary shares
0.01
99.99
Integrated International Payroll S. R. L.
See 10 below
Provision of  international payroll  services
Ordinary shares
0
100.00
Integrated International Payroll (Espana), S.L.
See 11 below
Provision of  international payroll  services
Ordinary shares
0
100.00
Integrated International Payroll Gmbh
See 12 below
Provision of  international payroll  services
Ordinary shares
0
100.00

Registered office addresses (all UK unless otherwise indicated):

1
Festival House, Jessop Avenue, Cheltenham, Gloucestershire, GL50 3SH, United Kingdom
2
Festival House, Jessop Avenue, Cheltenham, Gloucestershire, GL50 3SH, United Kingdom
3
Room 602, Wah Yuen Building, 149 Queen's Road Central, Hong Kong
4
Immeuble le Leeds -253, Boulevard du Leeds, Lille, 59777, France
5
Duna Tower, Budapest Nepfurdo u.22 113, Hungary
6
Krakowskie Przedmiescie 13, 5th Floor, Warsaw, Poland
7
50 Raffles Place 17-01, Singapore Land Tower, 048623, Singapore
8
5956 Sherry Lane, 20th Floor, Dallas, Texas 75225, United States of America
9
Suite 415, IOS Arboleda,Av. Roble No 660, Col. Valle Del Campestre, San Pedro Garza Garcia, Nuevo Leon, 66265, Mexico
10
Str. Gen. Athanasie Enescu NR.23 Parter Sectorul 1 010011 Bucuresti, Romania
11
Calle Manzanares 4, 28005, Madrid, Spain
12
Kleine Brudergasse 3, 01067 Dresden, Germany

IIPROLL MEXICO, S.A DE C.V is effectively a wholly-owned subsidiary of Ibidem Capital Limited.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 33 -
17
Debtors
Group
Company
2024
2023
2024
2023
Amounts falling due within one year:
£
£
£
£
Trade debtors
5,530,644
3,927,292
-
0
-
0
Corporation tax recoverable
549,919
249,538
-
0
-
0
Amounts owed by group undertakings
828,473
1,985,280
3,784,400
-
Other debtors
316,513
361,252
118,785
108,584
Prepayments and accrued income
2,763,218
2,115,738
-
0
-
0
9,988,767
8,639,100
3,903,185
108,584
Amounts falling due after more than one year:
Prepayments and accrued income
713,543
824,801
-
0
-
0
Deferred tax asset (note 18)
2,500,000
2,500,000
-
0
-
0
3,213,543
3,324,801
-
-
Total debtors
13,202,310
11,963,901
3,903,185
108,584

Debtors held are pledged as security for the borrowings of the group under a fixed and floating charge.

 

Amounts owed by group undertakings are unsecured, interest free, have no fixed repayment date and are repayable on demand.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 34 -
18
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:

Assets
Assets
2024
2023
Group
£
£
Tax losses
2,500,000
2,500,000
The company has no deferred tax assets or liabilities.
There were no deferred tax movements in the year.

The deferred tax asset set out above relates to the utilisation of tax losses against future expected profits.

19
Creditors: amounts falling due within one year
Group
Company
2024
2023
2024
2023
£
£
£
£
Trade creditors
2,206,525
1,802,214
-
0
-
0
Amounts owed to group undertakings
-
0
-
0
122,396
195,798
Corporation tax payable
2,783
132,814
-
0
-
0
Other taxation and social security
1,022,833
805,741
-
-
Other creditors
291,918
323,285
-
0
-
0
Accruals and deferred income
2,888,491
2,777,517
23,350
23,250
6,412,550
5,841,571
145,746
219,048

Amounts owed to group undertakings are unsecured, interest free, have no fixed repayment date and are repayable on demand.

20
Creditors: amounts falling due after more than one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Other borrowings
21
25,541,815
19,222,927
27,308,462
-
0
Accruals and deferred income
1,092,516
732,502
-
0
-
0
26,634,331
19,955,429
27,308,462
-
IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 35 -
21
Loans and overdrafts
Group
Company
2024
2023
2024
2023
£
£
£
£
Other loans
25,541,815
19,222,927
27,308,462
-
0
Payable after one year
25,541,815
19,222,927
27,308,462
-
0

Other loans are secured by fixed and floating charges over all the property and undertakings of the group. The subsidiary undertakings Integrated International Payroll Limited and Integrated International Payroll (Holdings) Limited are guarantors over this loan facility.

Other loans are repayable by monthly interest payments, with a full capital repayment due on the maturity date, 30 June 2026.

 

Interest was charged on other loans at a rate of 17% + EURIBOR per annum to June 2023 and is then charged at a rate of 17% + EURIBOR thereafter to the maturity date.

 

The group entered an arrangement prior to the current balance sheet date whereby these other loans were novated from the subsidiary undertaking, Integrated International Payroll Limited ("iiPay) to the parent company, Ibidem Capital Limited ("Ibidem") in return for the iiPay owing the same amount to Ibidem.

 

Transaction costs directly attributable to the loan have been prepaid on a group basis at the balance sheet date and will be released to the profit and loss account over the remaining loan term.

22
Share-based payment transactions

The group has a Management Incentive Plan (the "Incentive Plan") to award Management Incentive Units ("MIUs") to key employees and independent contractors of the group. The Incentive Plan is administered by the Board of the parent company, TeakiiPay Holdings LLC, and is subject to termination, at any time, as determined by the Board. As of 31 December 2024, 20,442 (2023: 20,661) Class C MIUs have been issued. These MIUs vest, conditional upon a contingent event, and in accordance with the terms of the Incentive Plan.

 

Class C MIUs are authorised under the parent company's Company Agreement, do not have an exercise price and do not expire until the parent company is dissolved. The Class C MIUs represent non-voting interest. Members holding Class C MIUs are subject in all respects to the parent company's Operating Agreement, including provisions relating to the distributions of such profits, information rights with respect to the parent company, competition and confidentiality.

 

No expense was recognised by the group in the year ended 31 December 2024 or 31 December 2023 in relation to these MIUs.

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 36 -
23
Share capital
Group and company
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 10p each
14,853,270
14,853,270
1,485,327
1,485,327

There is a single class of ordinary shares. There are no restrictions on the distribution of dividends and the repayment of capital.

24
Share premium account
Group
Company
2024
2023
2024
2023
£
£
£
£
At the beginning of the year
25,350,609
21,156,455
25,350,609
21,156,455
Issue of new shares
-
4,194,154
-
4,194,154
At the end of the year
25,350,609
25,350,609
25,350,609
25,350,609

The share premium reserve contains the premium arising on issue of equity shares, net of issue expenses.

 

During the prior year, the company allotted 1,255,735 Ordinary 10p shares at their nominal value for total consideration of £4,319,727.

25
Retranslation reserve
Group
£
At the beginning of the prior year
(199,156)
Other movements
33,752
At the end of the prior year
(165,404)
Other movements
174,762
At the end of the current year
9,358
Company
£
At the beginning of the prior year
-
At the end of the prior year
-
At the end of the current year
-
IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 37 -
26
Profit and loss reserves
Group
Company
2024
2023
2024
2023
£
£
£
£
At the beginning of the year
(35,504,352)
(32,361,250)
(302,219)
(328,120)
Profit/(loss) for the year
(5,420,846)
(3,143,102)
(5,473,653)
25,901
At the end of the year
(40,925,198)
(35,504,352)
(5,775,872)
(302,219)

Profit and loss reserves include all current and prior period retained profits and losses.

27
Operating lease commitments
Lessee

At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Group
Company
2024
2023
2024
2023
£
£
£
£
Within one year
114,210
126,782
-
-
Between two and five years
202,136
-
-
-
316,346
126,782
-
-

Future minimum lease payments under non-cancellable operating leases noted above relate to premises.

28
Events after the reporting date

On 27 February 2025, Teakiipay Holdings LLC, the immediate parent of Ibidem Capital Ltd ("Ibidem"), entered into an Equity Purchase Agreement whereby its entire equity interest in Ibidem has been sold to a third party, subject to FCA regulatory approval. The acquisition is on a debt-free and cash-free basis and on completion all third-party debt shall be repaid in full. Completion is expected in the second quarter of 2025.

29
Controlling party

The controlling party at the balance sheet date was the parent company, TeakiiPay Holdings LLC, a company registered in the United States of America.

30
Capital commitments

Neither the company nor the group had any capital commitments at the balance sheet date (2023: £Nil).

IBIDEM CAPITAL LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 38 -
31
Contingent liabilities and guarantees

As at the prior balance sheet date, the company had given a guarantee in respect of borrowings in a subsidiary undertaking of £19,222,927. This guarantee was secured by fixed and floating charges over all the assets, property and undertakings of the company. During the current year, these borrowings were novated to the company. Refer to note 21.

 

The group had no contingent liabilities at the balance sheet date (2023: £Nil).

32
Cash generated from/(absorbed by) group operations
2024
2023
£
£
Loss for the year after tax
(5,420,846)
(3,143,102)
Adjustments for:
Taxation charged/(credited)
72,500
(2,380,610)
Finance costs
5,541,636
4,031,366
Investment income
(46,203)
(17,384)
Amortisation and impairment of intangible assets
1,157,296
1,990,343
Depreciation and impairment of tangible fixed assets
153,522
140,012
Movements in working capital:
Increase in debtors
(914,961)
(2,567,034)
Decrease in creditors
(278,088)
(4,069,812)
Cash generated from/(absorbed by) operations
264,856
(6,016,221)
33
Analysis of changes in net debt - group
1 January 2024
Cash flows
Other non-cash changes
Exchange rate movements
31 December 2024
£
£
£
£
£
Cash at bank and in hand
2,418,741
381,932
-
198,490
2,999,163
Borrowings excluding overdrafts
(19,222,927)
(3,414,103)
(3,805,551)
(317,281)
(25,541,815)
(16,804,186)
(3,032,171)
(3,805,551)
(118,791)
(22,542,652)

Other non-cash movements in debt relate to payment-in-kind (PIK) interest accrued and not paid in cash during the year and therefore added to the closing balance of the relevant borrowings.

2024-12-312024-01-01falsefalseCCH SoftwareCCH Accounts Production 2025.100Mr T J JakobMr J K HustisMr T C HolmesMr V DavidsonMs J R OlkkolaMr W S Bellfalse08132942bus:Consolidated2024-01-012024-12-31081329422024-01-012024-12-3108132942bus:Director12024-01-012024-12-3108132942bus:Director32024-01-012024-12-3108132942bus:Director52024-01-012024-12-3108132942bus:Director62024-01-012024-12-3108132942bus:Director22024-01-012024-12-3108132942bus:Director42024-01-012024-12-3108132942bus:RegisteredOffice2024-01-012024-12-3108132942bus:Consolidated2024-12-31081329422024-12-3108132942bus:Consolidated2023-01-012023-12-31081329422023-01-012023-12-3108132942core:OtherResidualIntangibleAssetsbus:Consolidated2024-12-3108132942core:OtherResidualIntangibleAssetsbus:Consolidated2023-12-3108132942core:Goodwillbus:Consolidated2024-12-3108132942core:ComputerSoftwarebus:Consolidated2024-12-3108132942core:DevelopmentCostsCapitalisedDevelopmentExpenditurebus:Consolidated2024-12-3108132942core:Goodwillbus:Consolidated2023-12-3108132942core:ComputerSoftwarebus:Consolidated2023-12-3108132942core:DevelopmentCostsCapitalisedDevelopmentExpenditurebus:Consolidated2023-12-3108132942bus:Consolidated2023-12-3108132942core:LeaseholdImprovementsbus:Consolidated2024-12-3108132942core:FurnitureFittingsbus:Consolidated2024-12-3108132942core:ComputerEquipmentbus:Consolidated2024-12-3108132942core:LeaseholdImprovementsbus:Consolidated2023-12-3108132942core:FurnitureFittingsbus:Consolidated2023-12-3108132942core:ComputerEquipmentbus:Consolidated2023-12-31081329422023-12-3108132942core:ShareCapitalbus:Consolidated2024-12-3108132942core:ShareCapitalbus:Consolidated2023-12-3108132942core:SharePremiumbus:Consolidated2024-12-3108132942core:SharePremiumbus:Consolidated2023-12-3108132942core:OtherMiscellaneousReservebus:Consolidated2024-12-3108132942core:OtherMiscellaneousReservebus:Consolidated2023-12-3108132942core:RetainedEarningsAccumulatedLossesbus:Consolidated2023-12-3108132942core:ShareCapital2024-12-3108132942core:ShareCapital2023-12-3108132942core:SharePremium2024-12-3108132942core:SharePremium2023-12-3108132942core:RetainedEarningsAccumulatedLosses2024-12-3108132942core:RetainedEarningsAccumulatedLosses2023-12-3108132942core:ShareCapitalbus:Consolidated2022-12-3108132942core:SharePremiumbus:Consolidated2022-12-3108132942core:RetainedEarningsAccumulatedLossesbus:Consolidated2022-12-3108132942core:ShareCapital2022-12-3108132942core:SharePremium2022-12-3108132942core:RetainedEarningsAccumulatedLosses2022-12-3108132942core:SharePremiumbus:Consolidated2023-12-3108132942core:SharePremium2023-12-3108132942core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-12-3108132942core:ShareCapitalbus:Consolidated2023-01-012023-12-3108132942core:SharePremiumbus:Consolidated2023-01-012023-12-3108132942core:ShareCapital2023-01-012023-12-3108132942core:SharePremium2023-01-012023-12-3108132942bus:Consolidated2022-12-3108132942core:Goodwill2024-01-012024-12-3108132942core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3108132942core:ComputerSoftware2024-01-012024-12-3108132942core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-012024-12-3108132942core:LeaseholdImprovements2024-01-012024-12-3108132942core:FurnitureFittings2024-01-012024-12-3108132942core:ComputerEquipment2024-01-012024-12-3108132942core:UKTaxbus:Consolidated2024-01-012024-12-3108132942core:UKTaxbus:Consolidated2023-01-012023-12-3108132942core:ForeignTaxbus:Consolidated2024-01-012024-12-3108132942core:ForeignTaxbus:Consolidated2023-01-012023-12-3108132942bus:Consolidated12024-01-012024-12-3108132942bus:Consolidated12023-01-012023-12-3108132942bus:Consolidated22024-01-012024-12-3108132942bus:Consolidated22023-01-012023-12-3108132942bus:Consolidated32024-01-012024-12-3108132942bus:Consolidated32023-01-012023-12-3108132942core:Goodwillbus:Consolidated2023-12-3108132942core:ComputerSoftwarebus:Consolidated2023-12-3108132942core:DevelopmentCostsCapitalisedDevelopmentExpenditurebus:Consolidated2023-12-3108132942bus:Consolidated2023-12-3108132942core:Goodwillcore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3108132942core:ComputerSoftwarecore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3108132942core:DevelopmentCostsCapitalisedDevelopmentExpenditurecore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3108132942core:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3108132942core:Goodwillbus:Consolidated2024-01-012024-12-3108132942core:ComputerSoftwarebus:Consolidated2024-01-012024-12-3108132942core:DevelopmentCostsCapitalisedDevelopmentExpenditurebus:Consolidated2024-01-012024-12-3108132942core:LeaseholdImprovementsbus:Consolidated2023-12-3108132942core:FurnitureFittingsbus:Consolidated2023-12-3108132942core:ComputerEquipmentbus:Consolidated2023-12-3108132942core:LeaseholdImprovementsbus:Consolidated2024-01-012024-12-3108132942core:FurnitureFittingsbus:Consolidated2024-01-012024-12-3108132942core:ComputerEquipmentbus:Consolidated2024-01-012024-12-3108132942core:Subsidiary12024-01-012024-12-3108132942core:Subsidiary22024-01-012024-12-3108132942core:Subsidiary32024-01-012024-12-3108132942core:Subsidiary42024-01-012024-12-3108132942core:Subsidiary52024-01-012024-12-3108132942core:Subsidiary62024-01-012024-12-3108132942core:Subsidiary72024-01-012024-12-3108132942core:Subsidiary82024-01-012024-12-3108132942core:Subsidiary92024-01-012024-12-3108132942core:Subsidiary102024-01-012024-12-3108132942core:Subsidiary112024-01-012024-12-3108132942core:Subsidiary122024-01-012024-12-3108132942core:Subsidiary112024-01-012024-12-3108132942core:Subsidiary222024-01-012024-12-3108132942core:Subsidiary332024-01-012024-12-3108132942core:Subsidiary442024-01-012024-12-3108132942core:Subsidiary552024-01-012024-12-3108132942core:Subsidiary662024-01-012024-12-3108132942core:Subsidiary772024-01-012024-12-3108132942core:Subsidiary882024-01-012024-12-3108132942core:Subsidiary992024-01-012024-12-3108132942core:Subsidiary10102024-01-012024-12-3108132942core:Subsidiary11112024-01-012024-12-3108132942core:Subsidiary12122024-01-012024-12-3108132942core:CurrentFinancialInstruments2024-12-3108132942core:CurrentFinancialInstruments2023-12-3108132942core:CurrentFinancialInstrumentsbus:Consolidated2024-12-3108132942core:CurrentFinancialInstrumentsbus:Consolidated2023-12-3108132942core:Non-currentFinancialInstrumentsbus:Consolidated2024-12-3108132942core:Non-currentFinancialInstrumentsbus:Consolidated2023-12-3108132942core:Non-currentFinancialInstruments2024-12-3108132942core:Non-currentFinancialInstruments2023-12-3108132942core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-12-3108132942core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2023-12-3108132942core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3108132942core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3108132942core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-12-3108132942core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2023-12-3108132942core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3108132942core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3108132942bus:PrivateLimitedCompanyLtd2024-01-012024-12-3108132942bus:FRS1022024-01-012024-12-3108132942bus:Audited2024-01-012024-12-3108132942bus:ConsolidatedGroupCompanyAccounts2024-01-012024-12-3108132942bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP